Close

Enanta Pharma (ENTA) Affirms FDA Breakthrough Therapy Designation Given to AbbVie’s HCV Regimen

Go back to Enanta Pharma (ENTA) Affirms FDA Breakthrough Therapy Designation Given to AbbVie’s HCV Regimen